新和成(002001) - 2014 Q4 - 年度业绩预告

Financial Forecast Revision - The company revised its 2014 net profit forecast to between 793.91 million and 882.12 million CNY, representing a decrease of 10% to 0% compared to the previous year[3] - The previous forecast estimated a net profit of 882.12 million to 1.14676 billion CNY for 2014[3] - The performance forecast revision has not been audited by registered accountants[4] Reasons for Decline - The decline in net profit is attributed to a decrease in the sales price of the company's main product, Vitamin E[5] Investor Communication - The company expressed sincere apologies for any inconvenience caused to investors due to the performance forecast revision[6]